{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:41:33Z","timestamp":1781844093188,"version":"3.54.5"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Susac syndrome is an immune-mediated, ischemia-producing, occlusive microvascular endotheliopathy that threatens the brain, retina, and inner ear. There is a need for disease assessment tools that can help clinicians and patients to more easily, accurately, and uniformly track the clinical course and outcome of Susac syndrome. Ideally, such tools should simultaneously facilitate the clinical care and study of Susac syndrome and improve the value of future case reports. To meet this need, two novel clinical assessment tools were developed: the Susac Symptoms Form and the Susac Disease Damage Score. The former is a comprehensive self-report form that is completed by patients\/families to serially document the clinical status of a patient. The latter documents the extent of damage perceived by individual patients\/families and their physicians. Both forms were initially trialed with two particularly representative and instructive patients. The results of this trial are shared in this report.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Patient 1 is a 21-year-old Caucasian female who presented with an acute onset of headache, paresthesias, cognitive dysfunction, and emotional lability. Patient 2 is a 14-year-old Caucasian female who presented with an acute onset of headache, cognitive dysfunction, urinary incontinence, ataxia, and personality change. Both patients fulfilled criteria for a definite diagnosis of Susac syndrome: both eventually developed brain, retinal, and inner ear involvement, and both had typical \u201csnowball lesions\u201d on magnetic resonance imaging. The Susac Symptoms Form documented initial improvement in both patients, was sufficiently sensitive in detecting a subsequent relapse in the second patient, and succinctly documented the long-term clinical course in both patients. The Disease Damage Score documented minimal disease damage in the first patient and more significant damage in the second.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The Susac Symptoms Form and the Disease Damage Score are useful disease assessment tools, both for clinical care and research purposes. Their use could enhance the value of future case reports on Susac syndrome and could improve opportunities to learn from a series of such reports.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-023-03838-9","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:02:38Z","timestamp":1681344158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Use of disease assessment tools to increase the value of case reports on Susac syndrome: two case reports"],"prefix":"10.1186","volume":"17","author":[{"given":"Danielle R.","family":"Bullock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Vehe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Rennebohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"3838_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrneurol.2013.82","volume":"9","author":"J Dorr","year":"2013","unstructured":"Dorr J, Krautwald S, Wildemann B, et\u00a0al. Characteristics of Susac syndrome: a review of all reported cases. Nat Rev Neurol. 2013;9:307\u201316.","journal-title":"Nat Rev Neurol"},{"key":"3838_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jns.2012.05.021","volume":"322","author":"I Kleffner","year":"2012","unstructured":"Kleffner I, Dunning T, Lohmann H, et\u00a0al. A brief review of Susac syndrome. J Neurol Sci. 2012;322:35\u201340.","journal-title":"J Neurol Sci"},{"key":"3838_CR3","doi-asserted-by":"publisher","DOI":"10.1177\/1747493017751737","author":"R Rennebohm","year":"2018","unstructured":"Rennebohm R, Asdaghi N, Srivastava S, Gertner E. Guidelines for the treatment of Susac syndrome. An update. Int J Stroke. 2018. https:\/\/doi.org\/10.1177\/1747493017751737.","journal-title":"Int J Stroke"},{"issue":"9","key":"3838_CR4","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1080\/00207454.2016.1254631","volume":"127","author":"T Seifert-Held","year":"2017","unstructured":"Seifert-Held T, et\u00a0al. Susac\u2019s syndrome: clinical course and epidemiology in a central European population. Int J Neurosci. 2017;127(9):776\u201380. https:\/\/doi.org\/10.1080\/00207454.2016.1254631.","journal-title":"Int J Neurosci"},{"issue":"1","key":"3838_CR5","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12883-020-01892-0","volume":"20","author":"A Wilf-Yarkoni","year":"2020","unstructured":"Wilf-Yarkoni A, Elkayam O, Aizenstein O, et\u00a0al. Increased incidence of Susac syndrome: a case series study. BMC Neurol. 2020;20(1):332. https:\/\/doi.org\/10.1186\/s12883-020-01892-0.","journal-title":"BMC Neurol"},{"issue":"1","key":"3838_CR6","doi-asserted-by":"publisher","first-page":"5779","DOI":"10.1038\/s41467-019-13593-5","volume":"10","author":"CC Gross","year":"2019","unstructured":"Gross CC, Meyer C, Bhatia U, et\u00a0al. CD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome. Nat Commun. 2019;10(1):5779. https:\/\/doi.org\/10.1038\/s41467-019-13593-5.","journal-title":"Nat Commun"},{"issue":"6","key":"3838_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/jnen\/nlz031","volume":"78","author":"DP Agamanolis","year":"2019","unstructured":"Agamanolis DP, Klonk C, Bigley K, et\u00a0al. Neuropathological findings in Susac syndrome: an autopsy report. J Neuropathol Exp Neurol. 2019;78(6):515\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"3838_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/01913123.2019.1692117","volume":"43","author":"DP Agamanolis","year":"2019","unstructured":"Agamanolis DP, Prayson RA, Asdaghi N, et\u00a0al. Brain microvascular pathology in Susac syndrome\u2014an electron microscopy study of 5 cases. Ultrastruct Pathol. 2019;43(6):229\u201336. https:\/\/doi.org\/10.1080\/01913123.2019.1692117.","journal-title":"Ultrastruct Pathol"},{"key":"3838_CR9","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.121.318902","volume":"128","author":"Y Lei","year":"2021","unstructured":"Lei Y, Zhang J, Cara R, Schiavon CR, et\u00a0al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ Res. 2021;128:1323\u20136. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318902.","journal-title":"Circ Res"},{"issue":"3","key":"3838_CR10","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s13760-020-01554-5","volume":"121","author":"L Venditti","year":"2021","unstructured":"Venditti L, Rousseau A, Ancelet C, et\u00a0al. Susac syndrome following COVID-19 infection. Acta Neurol Belg. 2021;121(3):807\u20139. https:\/\/doi.org\/10.1007\/s13760-020-01554-5.","journal-title":"Acta Neurol Belg"},{"key":"3838_CR11","unstructured":"https:\/\/www.globalresearch.ca\/19916-eye-disorders-including-blindness-following-covid-vaccine-reported-europe\/5744219."},{"key":"3838_CR12","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1002\/art.39676","volume":"68","author":"DR Bullock","year":"2016","unstructured":"Bullock DR, Rivera S, Beardsley RM, et\u00a0al. Teen with encephalopathy: early recognition of and intervention for Susac Syndrome. Arthritis Rheumatol. 2016;68:1799.","journal-title":"Arthritis Rheumatol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-03838-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-023-03838-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-03838-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:02:49Z","timestamp":1681344169000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-023-03838-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3838"],"URL":"https:\/\/doi.org\/10.1186\/s13256-023-03838-9","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]},"assertion":[{"value":"17 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Both patients signed consent forms to participate in an IRB-approved clinical study of Susac syndrome conducted at Cleveland Clinic. This article is based on data generated by their participation in that study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients or the patient\u2019s legal guardian for publication of the case reports and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}